FORTE BIOSCIENCES, INC. Payments to Acquire Marketable Securities
FORTE BIOSCIENCES, INC. (FBRX) reported Payments to Acquire Marketable Securities of $51.16 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2020-04-23
- FORTE BIOSCIENCES, INC. payments to acquire marketable securities for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- FORTE BIOSCIENCES, INC. payments to acquire marketable securities for the quarter ending 2019-09-30 was $8.16M, a 66.25% decline year-over-year.
- FORTE BIOSCIENCES, INC. payments to acquire marketable securities for the quarter ending 2019-06-30 was $21.39M, a 34.41% increase year-over-year.
- FORTE BIOSCIENCES, INC. payments to acquire marketable securities for the quarter ending 2019-03-31 was $21.61M, a 72.46% increase year-over-year.
- FORTE BIOSCIENCES, INC. payments to acquire marketable securities for fiscal 2019 was $51.16M, a 27.68% decline from fiscal 2018.
- FORTE BIOSCIENCES, INC. payments to acquire marketable securities for fiscal 2018 was $70.75M, a 0.07% decline from fiscal 2017.
- FORTE BIOSCIENCES, INC. payments to acquire marketable securities for fiscal 2017 was $70.80M, a 207.77% increase from fiscal 2016.
- FORTE BIOSCIENCES, INC. payments to acquire marketable securities for fiscal 2016 was $23.00M, a 61.58% decline from fiscal 2015.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $8.16M derived: sum of 2 quarters · filed 2020-02-27 | $29.56M derived: sum of 3 quarters · filed 2020-02-27 | $51.16M 10-K · filed 2020-02-27 |
| 2019-09-30 | $8.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $29.56M derived: sum of 2 quarters · filed 2019-11-12 | $51.16M 10-Q · filed 2019-11-12 | $69.27M derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-06-30 | $21.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $43.00M 10-Q · filed 2019-08-08 | $61.11M derived: sum of 3 quarters · filed 2020-04-23 | $85.30M derived: sum of 4 quarters · filed 2020-04-23 |
| 2019-03-31 | $21.61M 10-Q · filed 2020-04-23 | $39.72M derived: sum of 2 quarters · filed 2020-04-23 | $63.91M derived: sum of 3 quarters · filed 2020-04-23 | $79.82M derived: sum of 4 quarters · filed 2020-04-23 |
| 2018-12-31 | $18.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $42.30M derived: sum of 2 quarters · filed 2020-02-27 | $58.22M derived: sum of 3 quarters · filed 2020-02-27 | $70.75M 10-K · filed 2020-02-27 |
| 2018-09-30 | $24.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $40.11M derived: sum of 2 quarters · filed 2019-11-12 | $52.64M 10-Q · filed 2019-11-12 | $91.79M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $15.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $28.44M 10-Q · filed 2019-08-08 | $67.60M derived: sum of 3 quarters · filed 2020-02-27 | $69.40M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $12.53M 10-Q · filed 2019-05-07 | $51.68M derived: sum of 2 quarters · filed 2020-02-27 | $53.48M derived: sum of 3 quarters · filed 2020-02-27 | $73.58M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $39.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $40.95M derived: sum of 2 quarters · filed 2020-02-27 | $61.05M derived: sum of 3 quarters · filed 2020-02-27 | $70.80M 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $21.89M derived: sum of 2 quarters · filed 2018-11-08 | $31.64M 10-Q · filed 2018-11-08 | $36.23M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $20.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $29.84M 10-Q · filed 2018-08-09 | $34.43M derived: sum of 3 quarters · filed 2019-02-27 | $39.71M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $9.75M 10-Q · filed 2018-05-11 | $14.33M derived: sum of 2 quarters · filed 2019-02-27 | $19.61M derived: sum of 3 quarters · filed 2019-02-27 | $27.47M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $9.87M derived: sum of 2 quarters · filed 2019-02-27 | $17.72M derived: sum of 3 quarters · filed 2019-02-27 | $23.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | $5.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $13.14M derived: sum of 2 quarters · filed 2017-11-08 | $18.42M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $7.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $13.14M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $5.28M 10-Q · filed 2017-05-23 | |||
| 2015-12-31 | $59.87M 10-K · filed 2018-03-09 |